Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toxoplasma | 17 | 2021 | 116 | 3.380 |
Why?
|
| Toxoplasmosis | 11 | 2021 | 66 | 2.780 |
Why?
|
| Plasmodium falciparum | 12 | 2020 | 47 | 1.740 |
Why?
|
| Protozoan Vaccines | 3 | 2019 | 11 | 1.200 |
Why?
|
| Protozoan Proteins | 9 | 2018 | 73 | 1.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 595 | 1.020 |
Why?
|
| Vaccines, Subunit | 3 | 2020 | 55 | 0.870 |
Why?
|
| Antigens, Protozoan | 3 | 2020 | 21 | 0.780 |
Why?
|
| Antimalarials | 3 | 2019 | 20 | 0.760 |
Why?
|
| Epitopes | 1 | 2020 | 255 | 0.700 |
Why?
|
| Protozoan Infections | 1 | 2019 | 3 | 0.690 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2021 | 49 | 0.670 |
Why?
|
| Spermine | 1 | 2019 | 24 | 0.660 |
Why?
|
| Spermidine | 1 | 2019 | 13 | 0.660 |
Why?
|
| Polyamines | 1 | 2019 | 37 | 0.640 |
Why?
|
| Membrane Transport Proteins | 3 | 2010 | 169 | 0.610 |
Why?
|
| Purines | 3 | 2010 | 93 | 0.590 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 445 | 0.590 |
Why?
|
| Nanoparticles | 2 | 2020 | 164 | 0.580 |
Why?
|
| Centrosome | 1 | 2016 | 22 | 0.540 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 12 | 0.540 |
Why?
|
| Cell Division | 1 | 2016 | 696 | 0.470 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 387 | 0.450 |
Why?
|
| HLA-B7 Antigen | 3 | 2020 | 7 | 0.410 |
Why?
|
| Immunoglobulin G | 5 | 2021 | 464 | 0.400 |
Why?
|
| Antiprotozoal Agents | 3 | 2019 | 32 | 0.380 |
Why?
|
| Photosynthetic Reaction Center Complex Proteins | 2 | 2001 | 27 | 0.370 |
Why?
|
| Antibodies, Protozoan | 3 | 2021 | 42 | 0.350 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1574 | 0.350 |
Why?
|
| Cyanobacteria | 2 | 2001 | 113 | 0.350 |
Why?
|
| Point-of-Care Testing | 2 | 2021 | 25 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2016 | 88 | 0.340 |
Why?
|
| Malaria | 2 | 2019 | 23 | 0.340 |
Why?
|
| Biological Transport | 1 | 2008 | 401 | 0.290 |
Why?
|
| Erythrocytes | 5 | 2010 | 254 | 0.290 |
Why?
|
| Immunoglobulin M | 4 | 2021 | 163 | 0.280 |
Why?
|
| Animals | 19 | 2020 | 27324 | 0.270 |
Why?
|
| Morocco | 3 | 2021 | 16 | 0.250 |
Why?
|
| Mice | 8 | 2020 | 11742 | 0.240 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2015 | 20 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2006 | 668 | 0.220 |
Why?
|
| Gene Deletion | 3 | 2016 | 342 | 0.210 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 64 | 0.210 |
Why?
|
| Light | 2 | 2001 | 292 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3211 | 0.200 |
Why?
|
| Methyltransferases | 3 | 2008 | 192 | 0.200 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2019 | 5 | 0.200 |
Why?
|
| Photosystem I Protein Complex | 1 | 2001 | 11 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 2 | 2020 | 168 | 0.190 |
Why?
|
| Host-Parasite Interactions | 2 | 2019 | 30 | 0.190 |
Why?
|
| Immunoassay | 2 | 2021 | 91 | 0.190 |
Why?
|
| Parasitemia | 2 | 2019 | 6 | 0.190 |
Why?
|
| HLA-A11 Antigen | 1 | 2020 | 2 | 0.190 |
Why?
|
| Interferon-gamma | 2 | 2014 | 451 | 0.190 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 31 | 0.190 |
Why?
|
| Peptides | 3 | 2014 | 647 | 0.180 |
Why?
|
| Parasites | 1 | 2020 | 8 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2880 | 0.180 |
Why?
|
| Trypanosomiasis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Trypanosoma | 1 | 2019 | 3 | 0.170 |
Why?
|
| Plasmodium | 1 | 2019 | 10 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2020 | 141 | 0.170 |
Why?
|
| Parasite Load | 1 | 2019 | 2 | 0.170 |
Why?
|
| Plasmodium yoelii | 1 | 2019 | 4 | 0.170 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 213 | 0.170 |
Why?
|
| Colombia | 1 | 2018 | 12 | 0.160 |
Why?
|
| France | 1 | 2018 | 48 | 0.160 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2018 | 43 | 0.160 |
Why?
|
| Enzymes | 1 | 2018 | 47 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2019 | 306 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2362 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2016 | 97 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 751 | 0.150 |
Why?
|
| Public Health | 1 | 2018 | 138 | 0.140 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.140 |
Why?
|
| Candida | 1 | 2006 | 18 | 0.140 |
Why?
|
| Cross-Priming | 1 | 2016 | 48 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1157 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2018 | 1296 | 0.130 |
Why?
|
| Quinolones | 1 | 2016 | 60 | 0.130 |
Why?
|
| Amino Acids | 1 | 2006 | 245 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 107 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2016 | 163 | 0.130 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.130 |
Why?
|
| Humans | 16 | 2021 | 89073 | 0.130 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 38 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 162 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1088 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 105 | 0.120 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 249 | 0.120 |
Why?
|
| Triclosan | 1 | 2013 | 10 | 0.110 |
Why?
|
| Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2013 | 12 | 0.110 |
Why?
|
| United States | 4 | 2018 | 6957 | 0.110 |
Why?
|
| Spleen | 1 | 2014 | 432 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2015 | 471 | 0.110 |
Why?
|
| Morpholinos | 1 | 2012 | 13 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1429 | 0.100 |
Why?
|
| Culture Media | 2 | 2006 | 147 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 50 | 0.100 |
Why?
|
| Phosphatidylcholines | 2 | 2008 | 48 | 0.100 |
Why?
|
| Phycobilisomes | 2 | 2001 | 8 | 0.090 |
Why?
|
| Benzamides | 1 | 2012 | 237 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 688 | 0.090 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2010 | 2 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 956 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2014 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 645 | 0.090 |
Why?
|
| Female | 8 | 2021 | 46014 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 805 | 0.090 |
Why?
|
| Tubulin | 1 | 2010 | 59 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2012 | 370 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 387 | 0.080 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 509 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 195 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 255 | 0.080 |
Why?
|
| Guanosine | 1 | 2008 | 30 | 0.080 |
Why?
|
| Adenine | 1 | 2008 | 88 | 0.080 |
Why?
|
| Boron Compounds | 1 | 2007 | 20 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1650 | 0.080 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 52 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2007 | 56 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 73 | 0.070 |
Why?
|
| Guanine | 1 | 2008 | 207 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 382 | 0.070 |
Why?
|
| HIV Infections | 1 | 2016 | 835 | 0.070 |
Why?
|
| Pyrazines | 1 | 2007 | 94 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2007 | 188 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2006 | 73 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 183 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 116 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 1240 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 887 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 247 | 0.060 |
Why?
|
| Permeability | 2 | 2015 | 137 | 0.060 |
Why?
|
| Methylation | 3 | 2010 | 268 | 0.060 |
Why?
|
| Pregnancy | 2 | 2021 | 3010 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2062 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2016 | 232 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 53 | 0.050 |
Why?
|
| Diuron | 1 | 2001 | 4 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2011 | 0.050 |
Why?
|
| Photosystem II Protein Complex | 1 | 2001 | 21 | 0.050 |
Why?
|
| Lighting | 1 | 2001 | 33 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 74 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 76 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 77 | 0.050 |
Why?
|
| Thylakoids | 1 | 2000 | 10 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 73 | 0.040 |
Why?
|
| Fluorescence | 1 | 2000 | 103 | 0.040 |
Why?
|
| Phenotype | 1 | 2006 | 2439 | 0.040 |
Why?
|
| Malaria, Falciparum | 2 | 2010 | 12 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 309 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 321 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2012 | 755 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 400 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 66 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 5320 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 148 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 486 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 6289 | 0.040 |
Why?
|
| Serine | 2 | 2008 | 104 | 0.040 |
Why?
|
| Hyphae | 1 | 2006 | 7 | 0.040 |
Why?
|
| Developing Countries | 1 | 2017 | 76 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 64 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 153 | 0.040 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oocysts | 1 | 2016 | 7 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1940 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 9237 | 0.030 |
Why?
|
| Microscopy | 1 | 2006 | 87 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 305 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 2412 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 69 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 149 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 887 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2010 | 439 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 26508 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 16 | 0.030 |
Why?
|
| Occludin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2006 | 206 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 81 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 327 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 280 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 283 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1855 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 123 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 466 | 0.030 |
Why?
|
| Apicomplexa | 1 | 2012 | 5 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 236 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 32 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 289 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 948 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 412 | 0.030 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2012 | 8 | 0.030 |
Why?
|
| Luciferases | 1 | 2012 | 128 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2012 | 22 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 153 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 19078 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1592 | 0.020 |
Why?
|
| Organelles | 1 | 2012 | 56 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 429 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5466 | 0.020 |
Why?
|
| Tetracyclines | 1 | 2010 | 4 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 135 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 374 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2657 | 0.020 |
Why?
|
| Floxuridine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 29 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 160 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 421 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 388 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 27 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 323 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1990 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25865 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 75 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 183 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2010 | 131 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 275 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3147 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 273 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3717 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 794 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 353 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 274 | 0.020 |
Why?
|
| Ethanolamine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 911 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 15 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2008 | 24 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 230 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 15 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 116 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 463 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 82 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 205 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 170 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1487 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 338 | 0.020 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2006 | 2 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 277 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 887 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 185 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 944 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3027 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1223 | 0.020 |
Why?
|
| Child | 1 | 2016 | 7149 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1215 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1652 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1975 | 0.010 |
Why?
|
| Male | 2 | 2016 | 42254 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 2281 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3374 | 0.010 |
Why?
|